Interestingly, a significant increase in transforming growth factor-beta (TGF-β) signalling (P < 0.05) was identified in DDIR negative tumours, in keeping with immune exclusion in this subgroup of breast tumours [27]. Here, TGFB1 is linked to breast neoplasm.